Antineoplaston Therapy in Treating Patients With Stage IV Melanoma

Clinical trial NCT00003509 · TERMINATED

Trial details

NCT number: NCT00003509
Sponsor: Burzynski Research Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IV Melanoma

Start date: 1996-03-27
Primary completion: 2005-02-14
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.